Status:
RECRUITING
ADOPT-PRESTAGE: Study Evaluating the Impact of the Program PRESTAGE
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Cancer
Oral Anticancer Drugs
Eligibility:
All Genders
70+ years
Phase:
NA
Brief Summary
As the proportion of oral anticancer treatments is continuously increasing, adherence appears as a major issue for patients' outcomes. Poor adherence affects particularly geriatric patients due among ...
Eligibility Criteria
Inclusion
- Patients older than 70 years,
- For which oral anticancer therapy has been initiated within the previous 45 days or will be started within 45 days
- For any type of cancer, solid or hematologic, any stage
- Estimated life expectancy\> 6 months
- Affiliation to social security or equivalent
- Patients who can answer questionnaires and protocol evaluations
- Informed consent signed by patients
- Domiciled within 50 km around the investigating center
Exclusion
- For patients with breast cancer, exclusive treatment with hormone therapy
- First-generation Hormone Therapy in Prostate Cancer
- Patient not available for regular follow-up whatever the cause (geographic, family, social, psychological)
- Any serious condition, ie serious physical or mental, leading to a disability permanent and likely to prevent the proper course of treatment
- Patient deprived of liberty or under guardianship
Key Trial Info
Start Date :
March 29 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
139 Patients enrolled
Trial Details
Trial ID
NCT03296150
Start Date
March 29 2018
End Date
March 1 2026
Last Update
May 3 2024
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de neuro-oncologie, Hôpital Pierre Wertheimer, HCL
Bron, France, 69500
2
Service de Gériatrie, Centre Hospitalier de Givors
Givors, France, 69700
3
Service d'oncologie médicale, Centre Hospitalier Universitaire de Grenbole
La Tronche, France, 38700
4
Service de Médecine du vieillissement, Hôpital Edouard Herriot, HCL
Lyon, France, 69003